Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 Balance Sheet

Balance Sheet

As of 2026-07-31

Swipe to see the full flow
Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 Balance SheetBalance sheet as of 2026-07-31. The chart shows assets, liabilities and equity at that date.Current liabilities$48.27 MLiabilities$125.00 MNon-current liabilities$76.73 MEquity$222.36 MGross equity(calculated)$918.78 MCurrent assets$226.27 MAssets$347.36 MNon-current assets$121.08 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term investmentsCash and cash equivalentsAccounts receivable, netDisposable medical equipment suppliesPrepaid expenses and other current assetsProperty and equipment, netLong-term investmentsOther long-term assetsRight-of-use assetsDepositsRestricted cashAccounts payableAccrued liabilitiesOperating lease liabilities, current portionLong-term debt, netOperating lease liabilities, net of current portionOther long-term liabilitiesAdditional paid-in capitalCommon Shares, $1.00 par value; 100,000,000 shares authorized as of July 31, 2026 and April 30, 2026; 59,271,885 issued and outstanding as of July 31, 2026 and 58,383,924 shares issued and outstanding as of April 30, 2026Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$48.27 MAccounts payableAccounts payable$25.96 MLiabilitiesLiabilities$125.00 MAccrued liabilitiesAccrued liabilities$22.29 MOperating lease liabilities, current portionOperating lease liabilities, current portion$23.00 KNon-current liabilitiesNon-current liabilities$76.73 MLong-term debt, netLong-term debt, net$72.50 MEquityEquity$222.36 MOperating lease liabilities, net of current portionOperating lease liabilities, net of current portion$3.93 MOther long-term liabilitiesOther long-term liabilities$306.00 KGross equity (calculated)Gross equity(calculated)$918.78 MCurrent assetsCurrent assets$226.27 MShort-term investmentsShort-term investments$130.35 MAssetsAssets$347.36 MCash and cash equivalentsCash and cash equivalents$68.56 MAccounts receivable, netAccounts receivable, net$15.41 MDisposable medical equipment suppliesDisposable medical equipment supplies$7.44 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$4.52 MProperty and equipment, netProperty and equipment, net$63.66 MNon-current assetsNon-current assets$121.08 MLong-term investmentsLong-term investments$45.79 MAdditional paid-in capitalAdditional paid-in capital$859.50 MOther long-term assetsOther long-term assets$6.20 MRight-of-use assetsRight-of-use assets$3.26 MDepositsDeposits$1.84 MRestricted cashRestricted cash$334.00 KCommon Shares, $1.00 par value; 100,000,000 shares authorized as of July 31, 2026 and April 30, 2026; 59,271,885 issued and outstanding as of July 31, 2026 and 58,383,924 shares issued and outstanding as of April 30, 2026Common Shares$59.27 MAccumulated deficitAccumulated deficit−$695.95 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$471.00 K
Chart details

Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-07-31. The chart shows assets, liabilities and equity at that date.

Assets
347,355,000 US dollars
Current assets
226,273,000 US dollars
Non-current assets
121,082,000 US dollars
Liabilities
124,998,000 US dollars
Current liabilities
48,269,000 US dollars
Non-current liabilities
76,729,000 US dollars
Equity
222,357,000 US dollars
Short-term investments
130,353,000 US dollars
Cash and cash equivalents
68,558,000 US dollars
Accounts receivable, net
15,406,000 US dollars
Disposable medical equipment supplies
7,438,000 US dollars
Prepaid expenses and other current assets
4,518,000 US dollars
Property and equipment, net
63,656,000 US dollars
Long-term investments
45,791,000 US dollars
Other long-term assets
6,196,000 US dollars
Right-of-use assets
3,263,000 US dollars
Deposits
1,842,000 US dollars
Restricted cash
334,000 US dollars
Accounts payable
25,961,000 US dollars
Accrued liabilities
22,285,000 US dollars
Operating lease liabilities, current portion
23,000 US dollars
Long-term debt, net
72,495,000 US dollars
Operating lease liabilities, net of current portion
3,928,000 US dollars
Other long-term liabilities
306,000 US dollars
Additional paid-in capital
859,504,000 US dollars
Common Shares, $1.00 par value; 100,000,000 shares authorized as of July 31, 2026 and April 30, 2026; 59,271,885 issued and outstanding as of July 31, 2026 and 58,383,924 shares issued and outstanding as of April 30, 2026
59,272,000 US dollars
Accumulated deficit
negative 695,948,000 US dollars
Accumulated other comprehensive loss
negative 471,000 US dollars
Gross equity (calculated)
918,776,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!